Back
55
Day Range
$9.34
$10.24
52-Week Range
$2.24
$12.34
Volume
883,954
50D / 200D Avg
$8.71
/
$7.86
Prev Close
$9.18
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.6 | 0.2 |
| P/B | 1.0 | 3.0 |
| ROE % | -27.6 | 3.6 |
| Net Margin % | -164.4 | 3.8 |
| Rev Growth 5Y % | 47.4 | 9.9 |
| D/E | 0.0 | 0.2 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 47.43% annually over 5 years — strong growth
Debt/Equity of 0.04 — conservative balance sheet
Negative free cash flow of -109.08M
PEG of 0.17 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 230147.16%
Capital efficient — spends only 0.63% of revenue on capex
Growth
Revenue Growth (5Y)
47.43%
Revenue (1Y)230194.59%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-27.57%
ROIC-22.70%
Net Margin-164.43%
Op. Margin-187.24%
Safety
Debt / Equity
0.04
Current Ratio9.39
Interest Coverage0.00
Valuation
P/E Ratio
-3.60
Forward P/EN/A
P/B Ratio1.00
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 230194.59% | Revenue Growth (3Y) | 102.78% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 47.43% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 85.21M | Net Income (TTM) | -140.11M |
| ROE | -27.57% | ROA | -24.72% |
| Gross Margin | 91.05% | Operating Margin | -187.24% |
| Net Margin | -164.43% | Free Cash Flow (TTM) | -109.08M |
| ROIC | -22.70% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.04 | Current Ratio | 9.39 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3.60 | Forward P/E | N/A |
| P/B Ratio | 1.00 | P/S Ratio | 5.92 |
| PEG Ratio | 0.17 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -21.63% | ||
| Market Cap | 504.39M | Enterprise Value | 465.56M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 85.21M | 37,000.0 | 20.72M | 3.13M | 18.04M |
| Net Income | -140.11M | -160.87M | -100.84M | -107.49M | -71.32M |
| EPS (Diluted) | -2.42 | -2.98 | -2.58 | -3.12 | -2.46 |
| Gross Profit | 77.58M | 37,000.0 | -76.37M | -77.12M | -43.32M |
| Operating Income | -159.55M | -187.84M | -112.87M | -110.03M | -71.33M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 566.71M | 560.38M | 339.89M | 261.85M | 353.49M |
| Total Liabilities | 61.05M | 49.78M | 32.06M | 30.51M | 34.38M |
| Shareholders' Equity | 505.66M | 510.61M | 307.83M | 231.34M | 319.11M |
| Total Debt | 21.41M | 24.61M | 14.67M | 16.12M | 16.45M |
| Cash & Equivalents | 60.24M | 149.34M | 249.11M | 52.35M | 153.00M |
| Current Assets | 413.13M | 434.93M | 296.59M | 220.51M | 256.28M |
| Current Liabilities | 43.99M | 29.15M | 18.95M | 15.73M | 16.34M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#44 of 148
Recent Activity
Entered
Full Throttle
Mar 26, 2026